Table 2.
Schizophrenia (n=25 539) |
Controls (n=25 539) |
||||||
---|---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | ||
Demographic factors | |||||||
Age | 1·03 | 1·03–1·03 | <0·0001 | 1·05 | 1·04–1·05 | <0·0001 | |
Sex | 1·11 | 1·04–1·17 | <0·0003 | 1·23 | 1·16–1·31 | <0·0001 | |
Socioeconomic status | |||||||
Medium | 1·64 | 1·55–1·73 | <0·0001 | 1·98 | 1·86–2·11 | <0·0001 | |
High | 2·17 | 2·00–2·36 | <0·0001 | 3·44 | 3·18–3·72 | <0·0001 | |
Marital status | 0·80 | 0·74–0·85 | <0·0001 | 1·42 | 1·34–1·51 | <0·0001 | |
Population group | |||||||
Jewish Ultraorthodox | 0·40 | 0·36–0·44 | <0·0001 | 0·34 | 0·30–0·39 | <0·0001 | |
Arab | 0·34 | 0·31–0·36 | <0·0001 | 0·27 | 0·25–0·28 | <0·0001 | |
Clinical factors | |||||||
Previous COVID-19 infection | 0·31 | 0·28–0·35 | <0·0001 | 0·04 | 0·04–0·04 | <0·0001 | |
Asthma | 0·97 | 0·87–1·10 | 0·72 | 1·11 | 0·98–1·26 | 0·10 | |
Diabetes | 1·18 | 1·09–1·26 | <0·0001 | 0·95 | 0·87–1·05 | 0·39 | |
Hypertension | 1·10 | 1·02–1·19 | <0·0001 | 0·95 | 0·86–1·00 | 0·26 | |
Obesity | 1·20 | 1·13–1·27 | <0·0001 | 1·04 | 0·97–1·13 | 0·20 | |
Smoking | 0·93 | 0·88–0·98 | 0·012 | 0·87 | 0·82–0·93 | <0·0001 | |
Chronic obstructive pulmonary disease | 1·69 | 1·50–1·91 | <0·0001 | 1·68 | 1·39–2·03 | <0·0001 | |
Hyperlipidaemia | 2·10 | 2·00–2·21 | <0·0001 | 2·54 | 2·41–2·68 | <0·0001 | |
Ischaemic heart disease | 1·66 | 1·47–1·87 | <0·0001 | 2·21 | 1·98–2·47 | 2·47 |
Reference group for sex is female; for socioeconomic status is low; for marital status is not being married; for population group is general; for COVID-19 infection is being infected; and not having the condition in all clinical factors. OR=odds ratio.